| Code: MTA10274 | Publication Date: Oct 2025 |
The market growth is primarily driven by the increasing demand for serological testing in diagnostics, rising prevalence of infectious diseases, and the growing need for rapid detection of diseases such as HIV, and hepatitis.
The Serological Testing Market is experiencing significant growth with key trends such as the increasing adoption of rapid diagnostic tests, particularly for infectious diseases like COVID-19, HIV, and hepatitis. The market is also changing since there are more outpatient and point-of-care tests. There is a clear trend toward using AI and automation in serological tests to make them more efficient and cut down on mistakes made by people. There is also a growing need for serological tests in prenatal and post-transfusion diagnostics, as well as for screening for chronic diseases. The market is changing as new non-invasive testing methods and home-based testing kits are always being developed.
The Serological Testing Market is evolving through advancements in multiplex serology testing, which allows the detection of multiple diseases with a single test. More accurate, faster, and cheaper testing methods are making serological tests more widely available. Also, new technologies like microfluidic devices and biosensors are becoming more popular in serological tests. Using machine learning algorithms in serological tests is helping to make them more accurate and faster. Also, diagnostic manufacturers and healthcare providers are working together more to make tests that are specific to new infectious diseases. The growth of testing infrastructure in developing areas is also helping the market develop.
Some of the leading companies include: